UK markets closed

Acura Pharmaceuticals, Inc. (ACUR)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0030-0.0070 (-70.00%)
At close: 12:40PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
Total revenue
1,563
1,563
3,570
Operating expenses
Research development
1,524
1,524
1,781
Selling general and administrative
1,253
1,253
2,547
Total operating expenses
2,777
2,777
4,328
Operating income or loss
-1,214
-1,214
-758
Interest expense
200
200
450
Total other income/expenses net
535
535
-
Income before tax
-879
-879
-1,208
Income tax expense
0
0
0
Income from continuing operations
-879
-879
-1,208
Net income
-879
-879
-1,208
Net income available to common shareholders
-879
-879
-1,208
Basic EPS
-0.04
-0.02
-0.04
Diluted EPS
-0.04
-0.02
-0.04
Basic average shares
32,320
56,801
32,320
Diluted average shares
32,320
56,801
32,320